Literature DB >> 18388896

Elevated soluble lectin-like oxidized LDL receptor-1 (sLOX-1) levels in obese postmenopausal women.

Tina E Brinkley1, Noriaki Kume, Hirokazu Mitsuoka, Dana A Phares, James M Hagberg.   

Abstract

We investigated the association between soluble lectin-like oxidized low-density lipoprotein receptor-1 (sLOX-1) levels and obesity in older women. Fifty-one postmenopausal women (10 lean, 22 overweight, and 19 obese) were included in this small retrospective analysis. Plasma sLOX-1 levels were measured using a chemiluminescent enzyme-linked immunoassay. Plasma levels of sLOX-1 were significantly higher in obese women (55.33 +/- 4.49 pg/ml) compared to lean (30.91 +/- 6.19 pg/ml, P = 0.002) and overweight women (38.31 +/- 4.18 pg/ml, P = 0.017). Plasma sLOX-1 levels were positively associated with body weight, BMI, total body fat, and trunk fat. The relationship between sLOX-1 and BMI was attenuated after adjustment for age, hormone replacement therapy, and body fat. In conclusion, obese women have higher sLOX-1 levels, which may reflect increased LOX-1 expression in adipose tissue.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18388896      PMCID: PMC2677801          DOI: 10.1038/oby.2008.213

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  11 in total

1.  Identification of soluble forms of lectin-like oxidized LDL receptor-1.

Authors:  T Murase; N Kume; H Kataoka; M Minami; T Sawamura; T Masaki; T Kita
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-03       Impact factor: 8.311

Review 2.  New insights into how adipocytes sense their triglyceride stores. Is cholesterol a signal?

Authors:  I Dugail; S Le Lay; M Varret; X Le Liepvre; G Dagher; P Ferré
Journal:  Horm Metab Res       Date:  2003-04       Impact factor: 2.936

Review 3.  Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders.

Authors:  Jawahar L Mehta; Jiawei Chen; Paul L Hermonat; Francesco Romeo; Giuseppe Novelli
Journal:  Cardiovasc Res       Date:  2005-12-01       Impact factor: 10.787

4.  Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations.

Authors:  M Maslowska; H Vu; S Phelis; A D Sniderman; B M Rhode; D Blank; K Cianflone
Journal:  Eur J Clin Invest       Date:  1999-08       Impact factor: 4.686

5.  PPARgamma regulates adipocyte cholesterol metabolism via oxidized LDL receptor 1.

Authors:  Patricia C Chui; Hong-Ping Guan; Michael Lehrke; Mitchell A Lazar
Journal:  J Clin Invest       Date:  2005-07-07       Impact factor: 14.808

6.  Visceral adiposity, increased adipocyte lipolysis, and metabolic dysfunction in obese postmenopausal women.

Authors:  B J Nicklas; E M Rogus; E G Colman; A P Goldberg
Journal:  Am J Physiol       Date:  1996-01

7.  Endurance exercise training raises high-density lipoprotein cholesterol and lowers small low-density lipoprotein and very low-density lipoprotein independent of body fat phenotypes in older men and women.

Authors:  Amy Halverstadt; Dana A Phares; Kenneth R Wilund; Andrew P Goldberg; James M Hagberg
Journal:  Metabolism       Date:  2007-04       Impact factor: 8.694

Review 8.  Roles of lectin-like oxidized LDL receptor-1 and its soluble forms in atherogenesis.

Authors:  N Kume; T Kita
Journal:  Curr Opin Lipidol       Date:  2001-08       Impact factor: 4.776

Review 9.  LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis.

Authors:  Mingyi Chen; Tomoh Masaki; Tatsuya Sawamura
Journal:  Pharmacol Ther       Date:  2002-07       Impact factor: 12.310

10.  Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome: a novel marker for early diagnosis.

Authors:  Kazutaka Hayashida; Noriaki Kume; Takatoshi Murase; Manabu Minami; Daisuke Nakagawa; Tsukasa Inada; Masaru Tanaka; Akira Ueda; Goro Kominami; Hirofumi Kambara; Takeshi Kimura; Toru Kita
Journal:  Circulation       Date:  2005-08-01       Impact factor: 29.690

View more
  18 in total

1.  The association between soluble lectin-like oxidized low-density lipoprotein receptor-1 levels and patients with isolated coronary artery ectasia.

Authors:  Mehmet Balin; Ahmet Celik; M Ali Kobat
Journal:  J Thromb Thrombolysis       Date:  2012-04       Impact factor: 2.300

2.  Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease.

Authors:  Oguzhan Ozturk; Yasar Colak; Ebubekir Senates; Yusuf Yilmaz; Celal Ulasoglu; Levent Doganay; Seyma Ozkanli; Yasemin Musteri Oltulu; Ender Coskunpinar; Ilyas Tuncer
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

3.  Soluble Lectin-Like Oxidized LDL Receptor 1 as a Possible Mediator of Endothelial Dysfunction in Patients With Metabolic Syndrome.

Authors:  S Civelek; M Kutnu; H Uzun; F Erdenen; E Altunoglu; G Andican; A Seven; A O Sahin; G Burcak
Journal:  J Clin Lab Anal       Date:  2014-05-05       Impact factor: 2.352

Review 4.  Innate immune activation in obesity.

Authors:  Carey N Lumeng
Journal:  Mol Aspects Med       Date:  2012-10-13

5.  Caloric restriction, aerobic exercise training and soluble lectin-like oxidized LDL receptor-1 levels in overweight and obese post-menopausal women.

Authors:  T E Brinkley; X Wang; N Kume; H Mitsuoka; B J Nicklas
Journal:  Int J Obes (Lond)       Date:  2010-09-21       Impact factor: 5.095

6.  Scavenger receptors and their potential as therapeutic targets in the treatment of cardiovascular disease.

Authors:  Sam L Stephen; Katie Freestone; Sarah Dunn; Michael W Twigg; Shervanthi Homer-Vanniasinkam; John H Walker; Stephen B Wheatcroft; Sreenivasan Ponnambalam
Journal:  Int J Hypertens       Date:  2010-08-17       Impact factor: 2.420

7.  Oxidized LDL receptor 1 (OLR1) as a possible link between obesity, dyslipidemia and cancer.

Authors:  Magomed Khaidakov; Sona Mitra; Bum-Yong Kang; Xianwei Wang; Susan Kadlubar; Giuseppe Novelli; Vinay Raj; Maria Winters; Weleetka C Carter; Jawahar L Mehta
Journal:  PLoS One       Date:  2011-05-26       Impact factor: 3.240

8.  Schizophrenia gene expression profile reverted to normal levels by antipsychotics.

Authors:  Benedicto Crespo-Facorro; Carlos Prieto; Jesus Sainz
Journal:  Int J Neuropsychopharmacol       Date:  2014-10-31       Impact factor: 5.176

Review 9.  Clinical and Preclinical Use of LOX-1-Specific Antibodies in Diagnostics and Therapeutics.

Authors:  Jonathan De Siqueira; Izma Abdul Zani; David A Russell; Stephen B Wheatcroft; Sreenivasan Ponnambalam; Shervanthi Homer-Vanniasinkam
Journal:  J Cardiovasc Transl Res       Date:  2015-09-18       Impact factor: 4.132

10.  Oxidized LDL triggers pro-oncogenic signaling in human breast mammary epithelial cells partly via stimulation of MiR-21.

Authors:  Magomed Khaidakov; Jawahar L Mehta
Journal:  PLoS One       Date:  2012-10-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.